Overview
- 6 public-safe observations are available for this inspection.
- 3 structured CFR citations are represented.
- 6 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
Reasonable precautions
Cited by Jazmine M Welcher, Andrew E Kay, Travelle D Mason, Steven M Galvez, Joseph Tibay, Emmanuel O Kerry
Inspection, segregation, handling of raw materials
Cited by Jazmine M Welcher, Andrew E Kay, Travelle D Mason, Steven M Galvez, Joseph Tibay, Emmanuel O Kerry
Equipment, containers, utensils
Cited by Jazmine M Welcher, Andrew E Kay, Travelle D Mason, Steven M Galvez, Joseph Tibay, Emmanuel O Kerry
Reasonable precautions
Cited by Jazmine M Welcher, Andrew E Kay, Travelle D Mason, Steven M Galvez, Joseph Tibay, Emmanuel O Kerry
Inspection, segregation, handling of raw materials
Cited by Jazmine M Welcher, Andrew E Kay, Travelle D Mason, Steven M Galvez, Joseph Tibay, Emmanuel O Kerry
Inspected site
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 110.80 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 110.80(a)(1) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 110.80(b)(7) | Cited across public-safe Form 483 observations | 2x |
Full 483 report
Get the verbatim text of all 6 observations
Every observation in full, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere